Todd Watanabe
Director, Reporting Person's title: President and Chief Executive Officer · 2 filings · Latest: May 4, 2026
Arcutis Biotherapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ARQT | Todd Watanabe | Director, Reporting Person's title: President and Chief Executive Officer | May 4, 2026 | Sale | $23.61 | 3,172 | $74.9K | 720,755 | |
ARQT | Todd Watanabe | Director, Reporting Person's title: President and Chief Executive Officer | Mar 2, 2026 | Sale | $25.18 | 37,349 | $940.5K | 785,957 |